[1]
“Rapid and sustained improvements in itch and sleep with tralokinumab treatment in patients with moderate-to-severe Atopic Dermatitis, a post hoc analysis of pooled data from ECZTRA 1 and 2”, J of Skin, vol. 5, no. 6, p. s61, Nov. 2021, doi: 10.25251/skin.5.supp.61.